Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Total Liabilities: 2019-2024

Historic Total Liabilities for Benitec Biopharma (BNTC) over the last 6 years, with Jun 2024 value amounting to $5.0 million.

  • Benitec Biopharma's Total Liabilities rose 118.32% to $7.6 million in Q1 2025 from the same period last year, while for Mar 2025 it was $7.6 million, marking a year-over-year increase of 118.32%. This contributed to the annual value of $5.0 million for FY2024, which is 16.42% up from last year.
  • Latest data reveals that Benitec Biopharma reported Total Liabilities of $5.0 million as of FY2024, which was up 16.42% from $4.3 million recorded in FY2023.
  • Benitec Biopharma's 5-year Total Liabilities high stood at $5.0 million for FY2024, and its period low was $1.3 million during FY2020.
  • Its 3-year average for Total Liabilities is $4.1 million, with a median of $4.3 million in 2023.
  • Its Total Liabilities has fluctuated over the past 5 years, first tumbled by 48.92% in 2020, then surged by 125.79% in 2022.
  • Over the past 5 years, Benitec Biopharma's Total Liabilities (Yearly) stood at $1.3 million in 2020, then climbed by 1.48% to $1.4 million in 2021, then surged by 125.79% to $3.1 million in 2022, then surged by 37.88% to $4.3 million in 2023, then grew by 16.42% to $5.0 million in 2024.